StonvexLoading…
StonvexStonvexStonvexCore line items from AVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.96B | $1.94B | $1.75B | $1.71B |
Operating Income | $354.00M | $306.00M | $258.00M | $190.00M |
Net Income | $193.00M | $180.00M | $171.00M | $155.00M |
EPS (Diluted) | $2.38 | $2.29 | $2.24 | $2.12 |
Total Assets | $8.36B | $7.94B | $7.70B | $7.42B |
Total Liabilities | $5.65B | $5.35B | $5.22B | $5.08B |
Cash & Equivalents | $19.00M | $30.00M | $35.00M | $13.43M |
Free Cash Flow OCF − CapEx | $-101.00M | $1.00M | $-52.00M | $-328.00M |
Shares Outstanding | 82.19M | 80.04M | 78.08M | 74.95M |